Health Exec Eyes Generic Plavix On The Horizon
A top health executive stunned analysts with a controversial statement Friday that a generic version of Bristol-Myers Squibb Co. and Sanofi-Aventis' blockbuster blood-thinner Plavix may hit the U.S. market as soon...To view the full article, register now.
Already a subscriber? Click here to view full article